Morgan Stanley Just Named Affirm Its Top Pick: Private Credit Fears Are Overdone and a May Catalyst Could Be Huge

Photo of David Moadel
By David Moadel Published

Quick Read

  • Morgan Stanley named Affirm Holdings (AFRM) a Top Pick with an Overweight rating and $76 price target, betting that private credit concerns are overdone while the May 12 Investor Forum likely triggers upward guidance revisions for GMV, margins, and EPS.

  • Affirm’s solid operational momentum—Q2 revenue up 30% YoY, GMV growth of 36%, and Affirm Card GMV nearly tripling—supports the bull case, though delinquencies and partner concentration warrant monitoring before investors increase positions.

  • The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Morgan Stanley Just Named Affirm Its Top Pick: Private Credit Fears Are Overdone and a May Catalyst Could Be Huge

© YakobchukOlena / Getty Images

Affirm Holdings (NASDAQ:AFRM) just earned a Top Pick designation from Morgan Stanley. Specifically, Morgan Stanley analyst James Faucette has named Affirm his firm’s Top Pick, carrying an Overweight rating and a $76 price target. For long-term investors watching the buy now, pay later space, this is a signal worth taking seriously.

The call rests on three pillars: upward estimate revision potential, private credit fears that Morgan Stanley views as overdone, and a strong near-term catalyst path. Affirm stock has faced pressure from private credit market concerns, yet the underlying funding data tells a different story. The firm’s latest securitization was 6x oversubscribed, and average funding costs have declined consistently from 7% in Q3 FY2025 to 6% in Q2 FY2026.

The near-term story centers on a specific date. Morgan Stanley believes the Affirm 2026 Investor Forum, scheduled for May 12, could be a major catalyst, with the company likely to raise its GMV, margin, and EPS targets at that event. That’s a concrete reason to pay attention to AFRM shares right now.

Ticker Company Firm Action Old Rating New Rating Old Target New Target
AFRM Affirm Holdings Morgan Stanley Top Pick Designation Overweight Overweight (Top Pick) N/A $76

The Analyst’s Case

Faucette’s core argument is that the market has mispriced Affirm’s funding risk. The company onboarded AB CarVal, adding approximately $600 million in forward flow capacity, and its equity capital required as a percentage of its total platform portfolio is expected to remain below 5%. The ABS funding market remains robust, and private credit fears don’t align with Affirm’s actual capital structure.

Operational momentum backs the bull case. Affirm’s Q2 FY2026 revenue rose 30% year over year to $1.123 billion, beating consensus by 6%. GMV rose 36% to $13.8 billion, while operating income rose to $117.6 million, up 2,821% year over year. CEO Max Levchin noted that “Affirm grew more than 5x the growth rate of overall U.S. credit card spend in 2025 and 4x the rate of e-commerce growth.”

Why the Move Matters Now

The May 12 Investor Forum is the clearest near-term inflection point. Morgan Stanley expects Affirm to raise its GMV, margin, and EPS targets at the event, which would force upward estimate revisions across Wall Street. The company’s full-year FY2026 guidance already calls for GMV of $48.3 to $48.85 billion and adjusted operating margins of 27% to 28%.

Affirm Card growth adds another layer. Affirm Card GMV nearly tripled to $2.2 billion in Q2 FY2026, with active cardholders more than doubling to 3.7 million. That product expansion diversifies revenue and deepens consumer engagement beyond a single checkout button.

What It Means for Your Portfolio

Morgan Stanley’s Top Pick designation carries real weight, particularly when paired with a specific catalyst date and a clear thesis around mispriced risk. If you believe private credit fears are overblown and that Affirm’s May forum delivers the guidance upgrade Faucette expects, the setup is compelling.

The risks remain real. 30-plus day delinquencies ex-Peloton rose 18 basis points year over year to 3%, and Affirm’s top five partners represent 46% of GMV, a concentration worth monitoring. Cautious investors should watch for whether the May forum delivers the target increases Morgan Stanley is anticipating before sizing up an AFRM stock position.

Photo of David Moadel
About the Author David Moadel →

David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.

His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.

With a master’s degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

Continue Reading

Top Gaining Stocks

RCL Vol: 5,459,971
UAL Vol: 13,118,073
CCL Vol: 37,518,047
MHK Vol: 1,231,821
DLTR Vol: 6,296,558

Top Losing Stocks

LYB Vol: 14,506,332
Dow
DOW Vol: 27,284,288
NFLX Vol: 125,548,860
CF Vol: 6,855,817
ALB Vol: 4,160,483